Medistim — Director's Dealing 2014

Oct 24, 2014

DISCLOSURE OF SHAREHOLDING IN MEDISTIM ASA

DISCLOSURE OF SHAREHOLDING IN MEDISTIM ASA

This joint disclosure is made by HealthInvest

Partners AB ("HealthInvest") for and on behalf of

itself as well as for and on behalf of HealthInvest

Value Fund and HealthInvest MicroCap Fund, in

accordance with Section 4-3 of the Norwegian

Securities Trading Act.

HealthInvest is an independent Swedish fund

management company under the supervision of the

Swedish Financial Supervisory Authority

(Finansinspektionen) since 2006. HealthInvest offers

actively managed healthcare funds aimed at

institutional and private clients. HealthInvest´s

investment approach includes a strong emphasis on low

valuations and in depth due diligence to find

potential catalysts to boost shareholder value.

On October 24, 2014 (with settle date October 28,

2014), HealthInvest acquired 50,000 shares in

MEDISTIM ASA ("MEDISTIM") for and on behalf of the

HealthInvest MicroCap Fund. As a result of the

transaction, HealthInvest MicroCap Fund and

HealthInvest Value Fund crossed the 5% threshold of

Section 4-3 of the Norwegian Securities Trading Act

calculated on an aggregate basis.

After the transaction mentioned above, HealthInvest

MicroCap Fund and HealthInvest Value Funds

shareholding in MEDISTIM amounts to 284,374 shares

and 665,196 shares respectively. This equals 1.57%

and 3.67% of the issued shares and votes in MEDISTIM.

After the transaction, the aggregate shareholding in

MEDISTIM over which HealthInvest is authorized to

exercise voting rights on a discretionary basis

amounts to 949,570 shares, equaling 5.25% of the

issued shares and votes in MEDISTIM.

The above calculations are based on a total number of

outstanding shares in MEDISTIM of 18,101,000 shares.

No rights to shares in MEDISTIM are held by

HealthInvest MicroCap Fund, HealthInvest Value Fund

or any other fund managed by HealthInvest.